Equifax (NYSE: EFX) CEO sells 37,791 shares after option exercise under 10b5-1 plan
Rhea-AI Filing Summary
Equifax CEO Mark W. Begor exercised stock options covering 37,791 shares of common stock at an exercise price of $112.46 per share on 2026-07-24, then sold 37,791 shares in multiple transactions at reported weighted-average prices including $175.8520, $169.8583 and $171.2619 per share, pursuant to a Rule 10b5-1 trading plan adopted on 10/28/2025. He reports 37,792 stock options remaining and additional indirect common stock holdings through several 2-year GRATs.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 37,791 shares ($2.26M approx. pre-tax spread)
Exercise and Sale
15 txns
Insider
Begor Mark W
Role
CEO
Sold
37,791 shs ($6.51M)
Approx. gross sale proceeds
$6.51M
Approx. exercise cost
$4.25M
Approx. pre-tax spread
$2.26M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option/Right to Buy F1, F11 | 37,791 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 37,791 | $112.46 | $4.25M |
| Sale | Common Stock F1, F3, F2 | 500 | $175.852 | $88K |
| Sale | Common Stock F1, F4, F2 | 600 | $169.8583 | $102K |
| Sale | Common Stock F1, F5, F2 | 600 | $168.4747 | $101K |
| Sale | Common Stock F1, F6, F2 | 1,300 | $174.9123 | $227K |
| Sale | Common Stock F1, F7, F2 | 2,936 | $173.7877 | $510K |
| Sale | Common Stock F1, F8, F2 | 4,112 | $172.79 | $711K |
| Sale | Common Stock F1, F9, F2 | 6,200 | $171.2619 | $1.06M |
| Sale | Common Stock F1, F10, F2 | 21,543 | $171.9986 | $3.71M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option/Right to Buy — 37,792 shares (Direct);
Common Stock — 271,890 shares (Direct);
Common Stock — 2,350 shares (Indirect, 2-yr Apr 2025 GRAT);
Common Stock — 21,284 shares (Indirect, 2-yr Dec 2025 GRAT);
Common Stock — 38,332 shares (Indirect, 2-yr Jun 2025 GRAT);
Common Stock — 2,018 shares (Indirect, 2-yr May 2025 GRAT);
Common Stock — 18,562 shares (Indirect, 2-yr May 2026 GRAT)
Footnotes (11)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.
- F2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
- F3. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $175.74 to $175.94, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F4. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $169.42 to $170.09, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F5. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $168.395 to $168.55, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F6. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $174.54 to $175.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F7. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $173.50 to $174.15, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F8. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $172.50 to $173.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F9. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $170.48 to $171.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F10. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $171.50 to $172.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F11. The option vested in three equal annual increments beginning 5/4/2019.
Key Figures
Options exercised: 37,791 shares
Exercise price: $112.46 per share
Shares sold: 37,791 shares
+5 more
8 metrics
Options exercised
37,791 shares
Stock options to buy Equifax common stock exercised on 2026-07-24
Exercise price
$112.46 per share
Conversion/exercise price of the stock options exercised on 2026-07-24
Shares sold
37,791 shares
Total Equifax common shares sold in multiple transactions on 2026-07-24
Representative sale price
$175.8520 per share
Weighted-average price for a 500-share sale of Equifax common stock
Options remaining
37,792 derivative securities
Stock option/rights position reported following the option exercise
Indirect holding – 2-yr Apr 2025 GRAT
2,350 shares
Equifax common stock held indirectly via a 2-yr Apr 2025 GRAT
Indirect holding – 2-yr Dec 2025 GRAT
21,284 shares
Equifax common stock held indirectly via a 2-yr Dec 2025 GRAT
ESPP shares included
226 shares
Common shares purchased through the Equifax Inc. 2020 Employee Stock Purchase Plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, dividend equivalent units, restricted stock units, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
dividend equivalent units financial
"Includes accrued dividend equivalent units for dividends reinvested"
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
restricted stock units financial
"dividends reinvested in corresponding restricted stock units through the Company's"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
GRAT financial
"nature_of_ownership: 2-yr Apr 2025 GRAT"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transactions did Equifax (EFX) CEO Mark Begor report on 2026-07-24?
Mark Begor reported exercising stock options for 37,791 Equifax shares at $112.46 per share and acquiring the same number of common shares, then selling 37,791 shares in multiple transactions. These trades were executed under a Rule 10b5-1 trading plan adopted on 10/28/2025.
What stock options did Equifax (EFX) CEO Mark Begor exercise?
Begor exercised stock options for 37,791 shares of Equifax common stock at an exercise price of $112.46 per share. The option vested in three equal annual increments beginning 5/4/2019 and carries an expiration date of 5/4/2028. After this exercise, 37,792 options remain reported.
What indirect Equifax (EFX) holdings does Mark Begor report through GRATs?
He reports indirect ownership of Equifax common stock through several 2-year GRATs: 2,350 shares (Apr 2025 GRAT), 21,284 (Dec 2025 GRAT), 38,332 (Jun 2025 GRAT), 2,018 (May 2025 GRAT) and 18,562 (May 2026 GRAT), all shown as post-transaction holdings.